Literature DB >> 11956056

Elevated levels of thymus- and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia.

Eishi Miyazaki1, Shin-ichi Nureki, Tetsujiro Fukami, Takehiko Shigenaga, Masaru Ando, Kazunobu Ito, Hiroaki Ando, Katsunori Sugisaki, Toshihide Kumamoto, Tomiyasu Tsuda.   

Abstract

Thymus- and activation-regulated chemokine (TARC/CCL17) is a lymphocyte-directed CC chemokine, which plays a role in the recruitment of CC chemokine receptor-4 positive T helper 2 (Th2) cells. In this study, we measured concentrations of TARC and Th2 cell-derived cytokines in bronchoalveolar lavage (BAL) fluid, as well as TARC concentrations in serum from patients with eosinophilic pneumonia and other interstitial lung diseases. TARC was significantly elevated in BAL fluids from patients with eosinophilic pneumonia (median, 240 pg/ml), whereas TARC was undetectable (< 7 pg/ml) in most cases of hypersensitivity pneumonitis, sarcoidosis, and idiopathic pulmonary fibrosis, as well as in healthy control subjects. Also, when present, quantities were less than 20 pg/ml. Elevated concentrations of interleukin (IL)-4, IL-5, and IL-13 were also detected in BAL fluid from patients with eosinophilic pneumonia. Interestingly, TARC concentrations in BAL fluids were closely correlated with the concentrations of IL-5 and IL-13. A serial examination showed that elevated TARC in BAL fluid rapidly fell to below detectable limits preceding decreases in IL-5 concentration and eosinophil percentage. Our results, in concordance with previous studies, demonstrate the potential activity of TARC for recruiting Th2 cells to the lungs and suggest a significant role for TARC in the pathogenesis of eosinophilic pneumonia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956056     DOI: 10.1164/ajrccm.165.8.2106110

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  14 in total

1.  Modulatory role for retinoid-related orphan receptor alpha in allergen-induced lung inflammation.

Authors:  Maisa Jaradat; Cliona Stapleton; Stephen L Tilley; Darlene Dixon; Christopher J Erikson; Joshua G McCaskill; Hong Soon Kang; Martin Angers; Grace Liao; Jennifer Collins; Sherry Grissom; Anton M Jetten
Journal:  Am J Respir Crit Care Med       Date:  2006-09-14       Impact factor: 21.405

Review 2.  Eosinophilic pneumonias.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

3.  Lovastatin inhibits antigen-induced airway eosinophilia without affecting the production of inflammatory mediators in mice.

Authors:  Y Chiba; S Sato; M Misawa
Journal:  Inflamm Res       Date:  2009-05-06       Impact factor: 4.575

Review 4.  What does elevated TARC/CCL17 expression tell us about eosinophilic disorders?

Authors:  Julien Catherine; Florence Roufosse
Journal:  Semin Immunopathol       Date:  2021-05-19       Impact factor: 9.623

5.  Circulating thymus and activation-regulated chemokine/CC chemokine ligand 17 is a strong candidate diagnostic marker for interstitial lung disease in patients with malignant tumors: a result from a pilot study.

Authors:  Hiromichi Yamane; Nobuaki Ochi; Tomoko Yamagishi; Yoshihiro Honda; Masami Takeyama; Nagio Takigawa
Journal:  Ther Clin Risk Manag       Date:  2015-06-17       Impact factor: 2.423

6.  Xiao-Qing-Long-Tang shows preventive effect of asthma in an allergic asthma mouse model through neurotrophin regulation.

Authors:  Ren-Shiu Chang; Shulhn-Der Wang; Yu-Chin Wang; Li-Jen Lin; Shung-Te Kao; Jiu-Yao Wang
Journal:  BMC Complement Altern Med       Date:  2013-09-08       Impact factor: 3.659

7.  Association between a Single Donor TARC/CCL17 Promotor Polymorphism and Obstructive Chronic Lung Allograft Dysfunction after Lung Transplantation.

Authors:  Kevin Budding; Jessica van Setten; Eduard A van de Graaf; Oliver A van Rossum; Tineke Kardol-Hoefnagel; Erik-Jan D Oudijk; C Erik Hack; Henderikus G Otten
Journal:  Front Immunol       Date:  2017-09-06       Impact factor: 7.561

8.  Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis.

Authors:  Yurika Yogo; Seitaro Fujishima; Takashi Inoue; Fumitake Saito; Takayuki Shiomi; Kazuhiro Yamaguchi; Akitoshi Ishizaka
Journal:  Respir Res       Date:  2009-08-29

9.  Higher serum CCL17 may be a promising predictor of acute exacerbations in chronic hypersensitivity pneumonitis.

Authors:  Yasunari Miyazaki; Koji Unoura; Tomoya Tateishi; Takumi Akashi; Tamiko Takemura; Makoto Tomita; Naohiko Inase; Yasuyuki Yoshizawa
Journal:  Respir Res       Date:  2013-05-25

10.  Clinical Characteristics and Factors Influencing the Occurrence of Acute Eosinophilic Pneumonia in Korean Military Personnel.

Authors:  Chang-gyo Yoon; Se Jin Kim; Kang Kim; Ji Eun Lee; Byung Woo Jhun
Journal:  J Korean Med Sci       Date:  2016-01-26       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.